CA2498267A1 - Methode pour traiter la dyserection et augmenter la libido chez l'homme - Google Patents
Methode pour traiter la dyserection et augmenter la libido chez l'hommeInfo
- Publication number
- CA2498267A1 CA2498267A1 CA002498267A CA2498267A CA2498267A1 CA 2498267 A1 CA2498267 A1 CA 2498267A1 CA 002498267 A CA002498267 A CA 002498267A CA 2498267 A CA2498267 A CA 2498267A CA 2498267 A1 CA2498267 A1 CA 2498267A1
- Authority
- CA
- Canada
- Prior art keywords
- testosterone
- steroid
- men
- enhancer
- isopropyl myristate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2498267A CA2498267C (fr) | 2001-08-29 | 2001-08-29 | Methode pour traiter la dyserection et augmenter la libido chez l'homme |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2498267A CA2498267C (fr) | 2001-08-29 | 2001-08-29 | Methode pour traiter la dyserection et augmenter la libido chez l'homme |
CA002420895A CA2420895C (fr) | 2000-08-30 | 2001-08-29 | Methode pour traiter la dyserection et augmenter la libido chez l'homme |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002420895A Division CA2420895C (fr) | 2000-08-30 | 2001-08-29 | Methode pour traiter la dyserection et augmenter la libido chez l'homme |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2498267A1 true CA2498267A1 (fr) | 2002-03-07 |
CA2498267C CA2498267C (fr) | 2010-10-26 |
Family
ID=34427647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2498267A Expired - Lifetime CA2498267C (fr) | 2001-08-29 | 2001-08-29 | Methode pour traiter la dyserection et augmenter la libido chez l'homme |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2498267C (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006061689A1 (fr) * | 2004-12-10 | 2006-06-15 | Alan Drizen | Systeme d'administration de medicaments topiques |
-
2001
- 2001-08-29 CA CA2498267A patent/CA2498267C/fr not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006061689A1 (fr) * | 2004-12-10 | 2006-06-15 | Alan Drizen | Systeme d'administration de medicaments topiques |
Also Published As
Publication number | Publication date |
---|---|
CA2498267C (fr) | 2010-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2330188T3 (es) | Composicion farmaceutica en forma de gel o de solucion a base de dihidrotestoterona, su procedimiento de preparacion y sus utilizaciones. | |
CA2646667C (fr) | Methode de traitement des bouffees de chaleur par des preparations transdermiquea ou transmucosiques | |
US20030139384A1 (en) | Method for treating erectile dysfunction and increasing libido in men | |
EP1510213B1 (fr) | Systèmes comprenant de la testostérone améliorants la pénétration et reduisants les irritations | |
DK2398457T3 (en) | TOPICAL FORMULATION clobetasol propionate LOW DOSE FOR TREATMENT OF DISEASES skin and mucous membranes | |
CA2419404A1 (fr) | Compositions et methodes de traitement de dysfonctionnements sexuels | |
JP2004524267A5 (fr) | ||
EP2173323B1 (fr) | Gel stimulant | |
US5747070A (en) | Methods for the treatment of herpes virus infections | |
US6500440B1 (en) | Topical preparation of alprostadil for the treatment of erectile dysfunction | |
US10993934B2 (en) | Topical compositions of dutasteride | |
CA2498267A1 (fr) | Methode pour traiter la dyserection et augmenter la libido chez l'homme | |
WO2004030665A1 (fr) | Composition de gel transparent destine a l'administration de sodium de diclofenac a travers la peau | |
RU2003108500A (ru) | Способ лечения эректильной дисфункции и повышения либидо у мужчин | |
US20120238535A1 (en) | Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes | |
WO2002102385A1 (fr) | Compositions comprenant un inhibiteur de cgmp pde5 pour administration transdermique au tissu erectile du penis | |
US9265721B2 (en) | Composition for promoting vascular smooth muscle relaxation | |
CN1491647A (zh) | 经皮式用于治疗阳痿和女性性冷淡并防治性病的组合物 | |
CN110996909A (zh) | 表面组合物 | |
US9452174B2 (en) | Oral transmucosal pharmaceutical compositions including testosterone and a C-SERM | |
US11141387B2 (en) | Memantine-containing transdermally absorbable liquid | |
US20160051563A1 (en) | Oral Transmucosal Pharmaceutical Compositions including Testosterone and an Aromatase Inhibitor | |
CN111419902A (zh) | 一种提高女性高潮概率的复合润滑剂及避孕套 | |
US20160051495A1 (en) | Oral Transmucosal Compositions including C-SERMs for Low Testosterone Levels in Men | |
KR20030041433A (ko) | 발기부전증 및 성 불감증 치료용 l-아르기닌 함유경피투여 제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210830 |